Phase III Interlaboratory Study of Fetax, Part 2: Interlaboratory Validation of an Exogenous Metabolic Activation System for Frog Embryo Teratogenesis Assay-Xenopus (Fetax)

References

• Dumont J. N., Schultz T. W., Buchanan M., Kao G. Frog Embryo Teratogenesis Assay. Xenopus (FETAX) - A Short-Term Assay Applicable to Complex Environmental Mixtures, Symposium on the Application of Short-Term Bioassays in the Analysis of Complex Environmental Mixtures III, M. D. Waters, S. S. Sanduh, J. Lewtas, L. Claxton, N. Chemoff, S. Nesnow. Plenum Press, New York (1983); 393–405
   Google Scholar
• Fort D. J., Dawson D. A., Bantle J. A Development of A Metabolic Activation System for the Frog Embryo Teratogeneses Assay. Xenopus (FETAX). Teratogenesis, Carcinogenesis, Mutagenesis (1988); 8: 251
   PubMedGoogle Scholar
• Fort D. J., Dawson D. A., Bantle J. A. Evaluation of the Developmental Toxicity of Five Compounds with the Frog Embryo Teratogenesis Assay: Xenopus and a Metabolic Activation System. Journal of Applied Toxicology (1989); 9: 377
   PubMed Web of Science ®Google Scholar
• Fort D. J., Rayburn J. R., DeYoung D. J., Bantle J. A. Assessing the Efficacy of an Aroclor 1254-Induced Exogenous Metabolic Activation System for FETAX. Drug and Chemical Toxicology (1991); 14: 143
   PubMed Web of Science ®Google Scholar
• Dawson D. A, Fort D. J., Smith G. J., Newell D. L., Bantle J. A. Evaluation of the Developmental Toxicity of Nicotine and Cotinine with Frog Embryo Teratogenesis Assay: Xenopus (FETAX). Teratogenesis, Carcinogenesis, Mutagenesis (1988); 8: 329
   PubMedGoogle Scholar
• Fort D. J., Bantle J. A. Use of Frog Embryo Teratogenesis Assay -Xenopus (FETAX) to Evaluate the Developmental Toxicity of Diphenylhydantoin. Fundamental and Applied Toxicology (1990); 14: 720
   PubMedGoogle Scholar
• Fort D. J., Bantle J. A. Analysis of the Mechanism of Isoniazid-Induced Developmental Toxicity with Frog Embryo Teratogenesis Assay: Xenopus (FETAX). Teratogenesis, Carcinogenesis, Mutagenesis (1990); 10: 463
   PubMedGoogle Scholar
• Fort D. J., Rayburn J. R., Bantle J. A. Evaluation of Acetaminophen-Induced Developmental Toxicity using FETAX. Drug and Chemical Toxicology (1992); 15: 329
   PubMed Web of Science ®Google Scholar
• Fort D. J., Stover E. L., Rayburn J. R., Hull M., Bantle J. A. Evaluation of the Developmental Toxicity of Trichloroethylene and Detoxification Metabolites using Xenopus. Teratogenesis, Carcinogenesis, Mutagenesis (1993); 13: 3
   Google Scholar
• Standard Guide for Conducting the Frog Embryo Teratogeneses Assay -Xenopus(FETAX); E 1439–91. American Society for Testing and Materials Annual Book of Standards (1991); 1104: 1119
   Google Scholar
• Bantle J. A., Dumont J. N., Finch R. A., Linder G. Atlas of Abnormalities: A Guide for the Performance of FETAX. Oklahoma State Publications Department, Stillwater, OK 1991
   Google Scholar
• Bantle J. A., et al. Initial Interlaboratory Validation Study of FETAX: Phase I Testing. Journal of Applied Toxicology (1994); 14: 213
   PubMed Web of Science ®Google Scholar
• Bantle J. A, et al. FETAX Interlaboratory Validation Study: Phase II Testing. Environmental Toxicology and Chemisty (1994); 13: 1629
   Web of Science ®Google Scholar
• Bantle J. A., et al. FETAX Interlaboratory Validation Study: Phase III-Part 1 Testing. Journal of Applied Toxicology (1995); 16: 517
   Web of Science ®Google Scholar
• Freireich E. J. Quantitative Comparison of Toxicity of Anti-Cancer Agents in Mouse Rat, Dog, Monkey and Man. Cancer Chemotherapy Report (1997); 50: 219
   Google Scholar
• Lucier G., McDaniel O., Brubaker P., Klein R. Effects of Methylmercury Chloride on Rat Liver Microsomal Enzymes. Chemical Biological Interactions (1971); 4: 265
   Web of Science ®Google Scholar
• Nash T. The Colorimetric Estimation of Formaldehyde by Means of the Hantzsch Reaction. Biochemistry (1955); 55: 412
   Google Scholar
• Bradford M. M. A Rapid Sensitive Method for the Quantic-ation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding. Analytical Biochemistry (1976); 72: 248
   PubMed Web of Science ®Google Scholar
• Dawson D. A., Bantle J. A. Development of a Reconstituted Water Media and Preliminary Validation of the Frog Embryo Teratogeneses Assay: Xenopus (FETAX). Journal of Applied Toxicology (1987); 7: 237
   PubMed Web of Science ®Google Scholar
• Steel R. G.D., Torrie J. H. Principles and Procedures of Statistics: A Biometrical Approach 2nd ed. McGraw-Hill, New York 1990
   Google Scholar
• Dawson D. A., Bantle J. A. Coadministration of Mehtylxanthines and Inhibitor Compounds Potentiates Teratogenicity in Xenopus Embryos. Teratology (1987); 35: 221
   PubMedGoogle Scholar
• Von Kreybig T. Die Teratogene Wirkung Cyclophosphamid Wahrend Der Embryonalen Entwicklungs-Phase Bei Der Ratte. Naunyn Schmiedeberg, Archives Pharmaxol (1965); 252: 173
   Google Scholar
• Chaube S., Kury G., Murphy M. L. Teratogenic Effects of Cyclophosphamide(NSC-26271) in the Rat. Cancer Chemotherapy Report (1978); 51: 363
   Google Scholar
• Singh S. The Teratogenicity of Cyclophosphamide (Endoran-Asta) in Rats. Indian Journal Medicine Research (1971); 59: 1128
   PubMed Web of Science ®Google Scholar
• Shogi R., Ohzu E. Effect of Endoxan on Developing Mouse Embryos. J. Fac Sc Hokkaido University (Ser VI) (1965); 15: 662
   Google Scholar
• Gibson J. E., Becker B. A. The Teratogenicity of Cyclophosphamide in Mice. Cancer Research (1968); 28: 475
   PubMed Web of Science ®Google Scholar
• Fritz H., Hess R. Effects of Cyclophosphamide on the Embryonic Development of the Rabbit. Agents Actions (1971); 2: 83
   PubMedGoogle Scholar
• McClure H. M., Wilk A. L., Horigan E. A., Pratt R. M. Induction of Craniofacial Malformations in Rhesus Monkeys (Macaca Mulatto) with Cyclophosphamide. Cleft Palate Journal (1979); 16: 248
   PubMedGoogle Scholar
• Manson J. M., Smith C. C. Influence of Cyclophosphamide and 4-Ketocyclophosphamide on Mouse Limb Development. Teratology (1977); 15: 291
   PubMedGoogle Scholar
• Mirkes F. E., Fantel A G., Greenway J. C., Shepard T. H. Teratogenicity of Cyclophosphamide Metabolites: Phosphoramide Mustard, Acrolein, and 4-Ketocyclophosphamide on Rat Embryos Cultured In Vitro. Toxicology and Applied Pharmacology (1981); 58: 322
   PubMed Web of Science ®Google Scholar
• Nishimura H., Nakai K. Congenital Malformations in Offspring Treated with Caffeine. Proceedings of the Society of Experimental Biology and Medicine (1960); 104: 140
   PubMed Web of Science ®Google Scholar
• Weathersbee P. S., Olsen L. K., Lodge H. R. Caffeine and Pregnancy. Postgraduate Medicine (1977); 62: 64
   PubMed Web of Science ®Google Scholar
• Borlee I., Lechat M. F., Bouchaert A., Misson C. Coffee Risk Factor During Pregnancy. Louvain Medicine (1978); 97: 279
   Google Scholar
• Heinonen O. P., Slone D., Shapiro S. Birth Defects and Drags in Pregnancy. Publishing Science Group Incorporated, Littleton, Mass 1977
   Google Scholar
• Linn S., Schoenbaum S. C., Menson R. R., Rosner B., Stabble-Eld P. G., Ryan K. J. No Association Between Coffee Consumption and Adverse Outcomes of Pregnancy. New England Journal of Medicine (1982); 306: 141
   PubMed Web of Science ®Google Scholar
• Parkhurst B. R., Warren-Hicks W., Noel L. E. Performance Characteristics of Effluent Toxicity Tests. Summarization and Evaluation of Data Environmental Toxicology Chemistry (1992); 2: 771
   Google Scholar
• Fort D. J., Propst T. L., Faulkner B. C., Stover E. L., Vollmuth T., Murray F. J. Evaluation of the Developmental Toxicity of Caffeine and Caffeine Metabolites using Frog Embryo Teratogenesis Assay-Xenopus (FETAX). Food and Chemical Toxicology, in press
   PubMed Web of Science ®Google Scholar